Johnson & Johnson is set to conduct the human trial of its Ebola vaccine by early next year to assist in providing protection to health care workers and individuals with increased risks of getting infected by the deadly virus.
Johnson & Johnson is set to conduct the human trial of its Ebola vaccine by early next year to assist in providing protection to health care workers and individuals with increased risks of getting infected by the deadly virus.
Share this Article
Recommended